|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2016. CA Cancer J Clin. 66:7–30. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zak Y, Rhoads KF and Visser BC: Predictors
of surgical intervention for hepatocellular carcinoma: Race,
socioeconomic status, and hospital type. Arch Surg. 146:778–784.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Artinyan A, Mailey B, Sanchez-Luege N,
Khalili J, Sun CL, Bhatia S, Wagman LD, Nissen N, Colquhoun SD and
Kim J: Race, ethnicity, and socioeconomic status influence the
survival of patients with hepatocellular carcinoma in the United
States. Cancer. 116:1367–1377. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhu Q, Li N, Zeng X, Han Q, Li F, Yang C,
Lv Y, Zhou Z and Liu Z: Hepatocellular carcinoma in a large medical
center of China over a 10-year period: Evolving therapeutic option
and improving survival. Oncotarget. 6:4440–4450. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Forner A, Reig ME, Rodriguez De Lope C and
Bruix J: Current strategy for staging and treatment: The BCLC
update and future prospects. Semin Liver Dis. 30:61–74. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ryerson AB, Eheman CR, Altekruse SF, Ward
JW, Jemal A, Sherman RL, Henley SJ, Holtzman D, Lake A, Noone AM,
et al: Annual report to the nation on the status of cancer,
1975-2012, featuring the increasing incidence of liver cancer.
Cancer. 122:1312–1337. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Nguyen MH, Garcia RT, Simpson PW, Wright
TL and Keeffe EB: Racial differences in effectiveness of
alpha-fetoprotein for diagnosis of hepatocellular carcinoma in
hepatitis C virus cirrhosis. Hepatology. 36:410–417. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Li J, Hansen BE, Peppelenbosch MP, De Man
RA, Pan Q and Sprengers D: Factors associated with ethnical
disparity in overall survival for patients with hepatocellular
carcinoma. Oncotarget. 8:15193–15204. 2017.PubMed/NCBI
|
|
10
|
El-Serag HB, Kramer J, Duan Z and Kanwal
F: Racial differences in the progression to cirrhosis and
hepatocellular carcinoma in HCV-infected veterans. Am J
Gastroenterol. 109:1427–1435. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Stewart SL, Kwong SL, Bowlus CL, Nguyen
TT, Maxwell AE, Bastani R, Chak EW and Chen MS Jr: Racial/ethnic
disparities in hepatocellular carcinoma treatment and survival in
California, 1988-2012. World J Gastroenterol. 22:8584–8595. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Alawadi ZM, Phatak UR, Kao LS, Ko TC and
Wray CJ: Race not rural residency is predictive of surgical
treatment for hepatocellular carcinoma: Analysis of the texas
cancer registry. J Surg Oncol. 113:84–88. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sloane D, Chen H and Howell C: Racial
disparity in primary hepatocellular carcinoma: Tumor stage at
presentation, surgical treatment and survival. J Natl Med Assoc.
98:1934–1939. 2006.PubMed/NCBI
|
|
14
|
Welzel TM, Graubard BI, Quraishi S, Zeuzem
S, Davila JA, El-Serag HB and McGlynn KA: Population-attributable
fractions of risk factors for hepatocellular carcinoma in the
United States. Am J Gastroenterol. 108:1314–1321. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wong LL, Hernandez B, Kwee S, Albright CL,
Okimoto G and Tsai N: Healthcare disparities in Asians and Pacific
Islanders with hepatocellular cancer. Am J Surg. 203:726–732. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Sawai H, Nishida N, Mbarek H, Matsuda K,
Mawatari Y, Yamaoka M, Hige S, Kang JH, Abe K, Mochida S, et al: No
association for Chinese HBV-related hepatocellular carcinoma
susceptibility SNP in other East Asian populations. BMC Med Genet.
13:472012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Makarova-Rusher OV, Altekruse SF, McNeel
TS, Ulahannan S, Duffy AG, Graubard BI, Greten TF and McGlynn KA:
Population attributable fractions of risk factors for
hepatocellular carcinoma in the United States. Cancer.
122:1757–1765. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lin J, Qiu M, Xu R and Sandra Dobs A:
Comparison of survival and clinicopathologic features in colorectal
cancer among African American, Caucasian and Chinese patients
treated in the United States: Results from the surveillance
epidemiology and end results (SEER) database. Oncotarget.
6:33935–33943. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lin MQ, Li YP, Wu SG, Sun JY, Lin HX,
Zhang SY and He ZY: Differences in esophageal cancer
characteristics and survival between Chinese and Caucasian patients
in the SEER database. Onco Targets Ther. 9:6435–6444. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Esnaola NF, Meyer JE, Karachristos A,
Maranki JL, Camp ER and Denlinger CS: Evaluation and management of
intrahepatic and extrahepatic cholangiocarcinoma. Cancer.
122:1349–1369. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhang H, Yang T, Wu M and Shen F:
Intrahepatic cholangiocarcinoma: Epidemiology, risk factors,
diagnosis and surgical management. Cancer Lett. 379:198–205. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Antwi SO, Mousa OY and Patel T: Racial,
ethnic, and age disparities in incidence and survival of
intrahepatic cholangiocarcinoma in the united states; 1995-2014.
Ann Hepatol. 17:604–614. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
National Cancer Institute. Overview of the
SEER Program. https://seer.cancer.gov/about/overview.html
|
|
25
|
National Cancer Institute. SEER*Stat
Databases. November. 2015, Submission. https://seer.cancer.gov/data-software/documentation/seerstat/nov2015/.
|
|
26
|
National Cancer Institute. SEER Program
Coding and Staging Manual. 2018, https://seer.cancer.gov/tools/codingmanuals/index.html
|
|
27
|
Davila JA and El-Serag HB: Racial
differences in survival of hepatocellular carcinoma in the United
States: A population-based study. Clin Gastroenterol Hepatol.
4:104–110. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Chen JG and Zhang SW: Liver cancer
epidemic in China: Past, present and future. Semin Cancer Biol.
21:59–69. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Sia D, Villanueva A, Friedman SL and
Llovet JM: Liver cancer cell of origin, molecular class, and
effects on patient prognosis. Gastroenterology. 152:745–761. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Thorgeirsson SS and Grisham JW: Molecular
pathogenesis of human hepatocellular carcinoma. Nat Genet.
31:339–346. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Farazi PA and DePinho RA: Hepatocellular
carcinoma pathogenesis: From genes to environment. Nat Rev Cancer.
6:674–687. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Lee YH, Hsu CY, Huang YH, Hsia CY, Chiou
YY, Su CW, Lin HC and Huo TI: Vascular invasion in hepatocellular
carcinoma: Prevalence, determinants and prognostic impact. J Clin
Gastroenterol. 48:734–741. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Yang D, Hanna DL, Usher J, LoCoco J,
Chaudhari P, Lenz HJ, Setiawan VW and El-Khoueiry A: Impact of sex
on the survival of patients with hepatocellular carcinoma: A
surveillance, epidemiology and end results analysis. Cancer.
120:3707–3716. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Aizer AA, Chen MH, McCarthy EP, Mendu ML,
Koo S, Wilhite TJ, Graham PL, Choueiri TK, Hoffman KE, Martin NE,
et al: Marital status and survival in patients with cancer. J Clin
Oncol. 31:3869–3876. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
He XK, Lin ZH, Qian Y, Xia D, Jin P and
Sun LM: Marital status and survival in patients with primary liver
cancer. Oncotarget. 8:64954–64963. 2016.PubMed/NCBI
|
|
36
|
Teo EK, Han SH, Terrault N, Luketic V,
Jensen D, Keeffe EB and Lok AS; HBV-OLT Study Group, . Liver
transplantation in patients with hepatitis B virus infection:
Outcome in Asian versus white patients. Hepatology. 34:126–132.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Hoehn RS, Hanseman DJ, Wima K, Ertel AE,
Paquette IM, Abbott DE and Shah SA: Does race affect management and
survival in hepatocellular carcinoma in the United States? Surg.
158:1244–1251. 2015. View Article : Google Scholar
|
|
38
|
Couto CA, Gelape CL, Calmet F, Martin P
and Levy C: Effect of ethnicity on liver transplant for
hepatocellular carcinoma. Exp Clin Transplant. 11:339–345. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Mathur AK, Osborne NH, Lynch RJ, Ghaferi
AA, Dimick JB and Sonnenday CJ: Racial/ethnic disparities in access
to care and survival for patients with early-stage hepatocellular
carcinoma. Arch Surg. 145:1158–1163. 2010. View Article : Google Scholar : PubMed/NCBI
|
